Search Results - robbert+creton

1 Results Sort By:
New use of CsA-type drugs for the prevention and treatment of neurodegenerative disorders, including Alzheimer’s disease
­Novel Method Repurposes CsA-Type Compounds to Treat Neurodegenerative Disease Overview Alzheimer’s disease remains a challenging disorder for drug development, with many candidate drugs failing clinical trials. Our novel method repurposes camphorsulfonic acid (CsA)-type compounds to treat early-stage Alzheimer’s disease, as well as...
Published: 6/29/2022   |   Inventor(s): Robbert Creton
Keywords(s):  
Category(s): Therapeutics, Neurodegenerative Disease